Patient Education - Teva
Patient Education - Teva supports organizations that educate people with Huntington’s disease, tardive dyskinesia, or schizophrenia and their caregivers to improve understanding of symptoms, management, and treatment.
Funder: Teva
Due Dates: At least 60 days before the event or needed decision (whichever is earlier)
Funding Amounts:
Summary: Supports education for people living with Huntington’s disease, tardive dyskinesia, or schizophrenia and their caregivers.
Key Information: Grants go to educational providers, not individuals.
Description
Teva’s Patient Education grants support programs that help patients and caregivers understand disease symptoms, early diagnosis, management, and treatment. Supported formats may include web activities, applications, brochures, live educational meetings, and publications. Teva considers requests from organizations that provide educational opportunities for patients and caregivers and are responsible for their programs’ content, quality, and scientific integrity.
For Huntington’s disease, priorities include progression, chorea, treatment options, research advances, and adherence. Tardive dyskinesia priorities include risk factors, disease burden, early management, treatment options, and discussions with healthcare teams. Schizophrenia priorities include treatment barriers, relapse prevention, long-acting injectables, and the patient perspective in care.
